New
Curida is a Contract Development and Manufacturing Organization (CDMO) within the Pharmaceutical and Diagnostic industry, based in Norway.
Description
Curida is specialized in development activities and full-scale commercial manufacturing of aseptic, sterile and non-sterile fill & finish. We have core competence in manufacturing of liquid pharmaceuticals: Blow-Fill-Seal (BFS) and Nasal Sprays. Curida also has a Bio-CDMO unit with GMP ready manufacturing facilities for monoclonal antibodies, serving the IVD industry and Pre-clinical stage companies
Type of Drugs Manufactured:
Small Molecule;Biologics;Medical Devices
CDMO Services:
Aseptic Fill Finish;Research & Development;Clinical Trials materials and logistics;Analytical Development
No. of Manufacturing Facilities:
3-5
High Potent Products capabilities:
OEB 3;OEB 4-5
Facilities Locations:
Europe
Regulatory Approvals for facilities:
EMA (Europe);ISO;GMP;NMPA (China);Health Canada
Manufacturing Technologies:
Blow-Fill-Seal (BFS);Inhalers;Liquids
Current Capacity:
Curida has available capacity in BFS ampoules and Nasal Sprays due to the recent investments made to increase our capacities.
Contact Information
Website
Phone
Address
Fornebu , Martin Linges vei 25, 1364, Norway
Zip/Post Code
1364
UPCOMING EVENTS
External Manufacturing Leaders Basel 2026
Exclusive event for senior external manufacturing leaders. Basel
External Manufacturing Leaders Dublin 2026
Exclusive event for senior external manufacturing leaders in Dublin, Wed 2nd December 2026
RESOURCES
SPOTLIGHT
Latest News
